T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Novartis
NVS
$290B
| $33.3M | 0.01% |
400,988
-4,687
| -1% | -$389K |
|
977
Healthpeak Properties
DOC
$14.3B
| $33.3M | 0.01% |
829,638
-3,920
| -0.5% | -$156K |
|
|
CEB
978
DELISTED
CEB Inc.
CEB
| $33.3M | 0.01% |
458,575
-47,527
| -9% | -$3.27M |
|
|
GIFI
979
DELISTED
Gulf Island Fabrication
GIFI
| $33M | 0.01% |
1,699,705
-119,675
| -7% | -$2.37M |
|
|
RAI
980
DELISTED
Reynolds American Inc
RAI
| $32.8M | 0.01% |
1,020,156
-4,180
| -0.4% | -$132K |
|
|
HME
981
DELISTED
HOME PROPERTIES, INC
HME
| $32.8M | 0.01% |
499,710
+482,820
| +2,859% | +$30.8M |
|
982
Outfront Media
OUT
$5.31B
| $32.7M | 0.01% |
1,237,669
-750,311
| -38% | -$18.3M |
|
983
Modine Manufacturing
MOD
$10.9B
| $32.6M | 0.01% |
2,393,850
-36,700
| -2% | -$458K |
|
984
Gentex
GNTX
$4.97B
| $32.5M | 0.01% |
1,798,342
-14,120
| -0.8% | -$235K |
|
985
Consolidated Edison
ED
$40B
| $32.5M | 0.01% |
491,974
+17,710
| +4% | +$1.11M |
|
986
Culp Inc
CULP
$44.2M
| $32.4M | 0.01% |
1,494,817
+140,702
| +10% | +$2.71M |
|
|
TCF
987
DELISTED
TCF Financial Corporation
TCF
| $32.3M | 0.01% |
2,030,646
-288
| -0% | -$4.43K |
|
|
EFOR
988
Everforth Inc
EFOR
$1.33B
| $31.8M | 0.01% |
957,380
-1,583,710
| -62% | -$47.6M |
|
989
Matsons
MATX
$6.45B
| $31.7M | 0.01% |
919,351
+24,000
| +3% | +$736K |
|
990
Parker-Hannifin
PH
$133B
| $31.7M | 0.01% |
245,485
+1,110
| +0.5% | +$136K |
|
991
Ciena
CIEN
$64.3B
| $31.3M | 0.01% |
1,614,565
+430,160
| +36% | +$7.18M |
|
992
Steven Madden
SHOO
$3.45B
| $31.2M | 0.01% |
1,468,851
-26,127
| -2% | -$557K |
|
|
MNTA
993
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $31.2M | 0.01% |
2,588,612
-17,800
| -0.7% | -$203K |
|
994
Maximus
MMS
$2.88B
| $31.1M | 0.01% |
568,000
+17,400
| +3% | +$846K |
|
|
NLSN
995
DELISTED
Nielsen Holdings plc
NLSN
| $31.1M | 0.01% |
696,240
-100,221
| -13% | -$4.29M |
|
996
Paychex
PAYX
$43.3B
| $30.9M | 0.01% |
668,716
+3,410
| +0.5% | +$157K |
|
|
GLOG
997
DELISTED
GASLOG LTD
GLOG
| $30.8M | 0.01% |
1,514,360
-14,480
| -0.9% | -$284K |
|
998
PDF Solutions
PDFS
$2.14B
| $30.8M | 0.01% |
2,072,161
+260,160
| +14% | +$3.4M |
|
999
AptarGroup
ATR
$8.42B
| $30.7M | 0.01% |
459,660
-18,500
| -4% | -$1.17M |
|
1000
Safety Insurance
SAFT
$1.52B
| $30.7M | 0.01% |
479,365
+417,000
| +669% | +$25M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.